Most Recent
SmileDirectClub can’t get its facts straight, Invisalign claims
The maker of the popular Invisalign dental aligners has sued competitor SmileDirectClub for allegedly misleading consumers about the cost and efficacy of its direct-to-consumer teeth alignment kits.
Arrium lenders hit with extra costs after rejecting $10M settlement offers
A group of banks that failed to prove steel giant Arrium falsified representations on loan drawdown notices ahead of its $2.8 billion collapse have been ordered to pay indemnity costs after a court found they rejected $10 million settlement offers three days into the trial.
Dixon Advisory hit with second class action over advice fees
Dixon Advisory faces a second class action on behalf of investors who claim they suffered significant financial loss when the advice firm and its directors allegedly encouraged the purchase of high risk, high fee securities for their own financial gain.
Hopping mad Brick Lane Brewing accuses Better Beer of ripping off brand
Melbourne craft beer producer Brick Lane Brewing Co has filed proceedings accusing three companies behind the zero carb Better Beer of ripping off its packaging in breach of the Australian Consumer Law.
Barrister faces discipline after ‘gut-feeling’ prompts unfounded allegations against solicitor
A Sydney-based barrister has been reprimanded for relying on his “gut feeling” in making baseless accusations of misconduct against the principal of a law firm.
‘Capricious’ conduct by Morrison government dooms Beetaloo gas contract
A judge has voided contracts between the Morrison government and a subsidiary of Empire Energy for gas exploration in the Beetaloo Basin after finding the decision to enter the agreement in the midst of litigation was "legally unreasonable or capricious".
Biogen wins discovery for potential IP lawsuit against Sandoz
Swiss pharmaceutical company Biogen has won discovery of documents sent from Sandoz to the Therapeutic Goods Administration, as it weighs a third patent infringement lawsuit to protect its multiple sclerosis drug against generic reproductions.
Judge shoots down ‘audacious’ McMillan Shakespeare claim for surplus class action funds
A judge has rejected an "audacious" attempt by McMillan Shakespeare to recoup a surplus of funds left over after a $9.5 million class action settlement was distributed to registered group members.
In class action appeal, Ford says it’s not on hook for damages for fixed cars
Ford has challenged its loss in a class action over its allegedly defective PowerShift transmissions, arguing group members who have had their cars repaired are not entitled to damages.
Insurer Vero may be dragged into combustible cladding class action
The applicant in a class action against Fairview Architectural over allegedly combustible cladding is add insurer Vero Insurance as a respondent, after revealing the cladding manufacturer may have $190 million in insurance to cover the class action's claims.